Total parenteral nutrition (TPN) involves administering all necessary nutrients intravenously through a central venous catheter when the digestive system cannot be used. A hypertonic nutrient solution containing glucose, proteins, lipids, electrolytes, vitamins and minerals is infused through a catheter placed in the superior vena cava. TPN requires careful monitoring to prevent complications like infection and maintains normal body functioning when enteral nutrition is not possible.
Iv fluid therapy (types, indications, doses calculation)kholeif
All what you need to know intravenous fluids, types, indications, contraindications, how to calculate fluid rate and drug dosages.
Embed code (http://www.slideshare.net/slideshow/embed_code/16138690)
In this presentation i have tried to explain in details about the Total Parenteral Nutrition (TPN) , what is it, who needs it, and how to prepare it and the necessary procedure with instructions. It is very useful for the individuals from Nutrition, Nursing, Pharmacists, and Medical background.
This PPT gives an idea to MBBS students about the Type of fluids, Calculating the daily requirements as well as the drop rate to be used in day today clinical practice.
Central Venous Catheter Care- A Nursing skill Tse Sona
- Shared on the request of al the delegates who attended and those who couldn't attend the webinar on "CVC care- A Nursing Skill'' due to limited seats. I hope it will be helpful to all
A brief awareness and knowledge about the insertion of NGT nasogastric Tube and feeding through it.
It contains an introduction, procedure, equipment needed, method of feeding etc
Iv fluid therapy (types, indications, doses calculation)kholeif
All what you need to know intravenous fluids, types, indications, contraindications, how to calculate fluid rate and drug dosages.
Embed code (http://www.slideshare.net/slideshow/embed_code/16138690)
In this presentation i have tried to explain in details about the Total Parenteral Nutrition (TPN) , what is it, who needs it, and how to prepare it and the necessary procedure with instructions. It is very useful for the individuals from Nutrition, Nursing, Pharmacists, and Medical background.
This PPT gives an idea to MBBS students about the Type of fluids, Calculating the daily requirements as well as the drop rate to be used in day today clinical practice.
Central Venous Catheter Care- A Nursing skill Tse Sona
- Shared on the request of al the delegates who attended and those who couldn't attend the webinar on "CVC care- A Nursing Skill'' due to limited seats. I hope it will be helpful to all
A brief awareness and knowledge about the insertion of NGT nasogastric Tube and feeding through it.
It contains an introduction, procedure, equipment needed, method of feeding etc
Total enteral nutrition and total parenteral nutrition in critically ill pat...Prof. Mridul Panditrao
Prof. mridul panditrao, discusses intricate problems of starvation, the pathophysiological changes, Total enteral nutrition, total parenteral nutrition, various protocols etc...
this presentation is about what is enteral feeding and how it is being carried out etc., it also gives information about classification based on duration of feeding. there is an information about infusion techniques and the time required for it.
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to CareVITASAuthor
This webinar helps clinicians understand the unique healthcare needs of the LGBTQ+ community, primarily in relation to end-of-life care. Topics include social and cultural background and challenges, healthcare disparities, advanced care planning, and strategies for reaching the community and improving quality of care.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
COVID-19 PCR tests remain a critical component of safe and responsible travel in 2024. They ensure compliance with international travel regulations, help detect and control the spread of new variants, protect vulnerable populations, and provide peace of mind. As we continue to navigate the complexities of global travel during the pandemic, PCR testing stands as a key measure to keep everyone safe and healthy. Whether you are planning a business trip, a family vacation, or an international adventure, incorporating PCR testing into your travel plans is a prudent and necessary step. Visit us at https://www.globaltravelclinics.com/
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...The Lifesciences Magazine
Deep Leg Vein Thrombosis occurs when a blood clot forms in one or more of the deep veins in the legs. These clots can impede blood flow, leading to severe complications.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...
Total Parenteral Nutrition: An Intro
1.
2. Enteral nutrition
• the delivery of nutrients in liquid form directly into
the stomach, duodenum, or jejunum.
Parenteral nutrition
• administration of nutriment intravenously.
• nutrition which is delivered through a system other
than the digestive system.
Total Parenteral Nutrition (TPN)
• intravenous administration (via a central venous
catheter) of the total nutrient requirements of a
patient with gastrointestinal dysfunction.
3. Total Parenteral Nutrition
Also called central parenteral nutrition (CPN) or
‘hyperal’ (hyperalimentation).
[The term ‘hyperalimentation’ is a misnomer because it
incorrectly implies that nutrients are supplied in excess
of needs].
Large amounts of nutrients in a hypertonic solution can
be supplied via TPN. The catheter is surgically placed
into the superior vena cava.
The reason that larger amounts of nutrients in a
hypertonic solution can be supplied via the superior
vena cava than with peripheral parenteral nutrition is
that the superior vena cava has a much larger diameter
and a higher blood flow rate, both of which quickly
dilute the TPN solution.
4. Definition
Total parenteral nutrition (TPN) is a way of
supplying all the nutritional needs of the body by
bypassing the digestive system and dripping
nutrient solution/s directly into a vein.
The administration of a nutritionally adequate
hypertonic solution (consisting of glucose, protein
hydrolysates, minerals, and vitamins) through an
indwelling catheter into the superior vena cava or
other main vein.
Normally TPN is administered in a hospital, but
under certain conditions and with proper patient
and caregiver education, it may also be used at
home for long-term therapy (HPA).
Ideally, TPN provides all the nutrients in the
correct quantities to ensure the body functions
normally.
5. Types of PN
2 types of IV (or parenteral) nutrition.
Partial parenteral nutrition (PPN) :
- given for short periods of time,
- to replace some of the nutrients required daily and
only supplements a normal diet.
Total parenteral nutrition (TPN) :
- given to patients who can’t eat anything and must
receive all nutrients required daily through an
intravenous line.
Home parenteral nutrition (HPN) : usually requires a CVC
(central venous catheter), which must first be inserted in a
fully equipped medical facility. After it is inserted, therapy
can continue at home.
6. Parenteral nutrition is administered outside the
digestive tract, intravenously.
Enteral nutrition encompasses oral and tube feedings
into the digestive tract.
General rule : ‘if the gut works, use it’.
The GI tract should be used if possible because it tends
to atrophy when not used. Gut bacteria can translocate
to the circulatory system through an atrophied GI tract
and increase the risk of infection.
Peripheral parenteral nutrition (PPN) or
Peripheral venous nutrition (PVN)
nutrients are supplied via a peripheral vein, usually a
vein in the arm.
7. PPN feedings usually supplement enteral feedings.
Large amounts of nutrients cannot be supplied via a
peripheral vein, because these relatively small veins
cannot tolerate the rush of fluid into the vein that
occurs when a hypertonic solution is introduced into the
circulatory system.
Body fluids have an osmolarity of about 300 mOsm.
The introduction of a hypertonic solution into a body
compartment will cause an osmotic gradient, resulting
in a fluid shift.
WHAT HAPPENS ?
When a hypertonic solution is introduced into a small
vein with a low blood flow, fluid from the surrounding
tissue moves into the vein due to osmosis. The area
can become inflamed, and thrombosis can occur.
8.
9. Osmolarity of Solutions
Proteins and carbohydrates both contribute to
hypertonicity.
Fat being isotonic, can be administered peripherally.
However, if the patient has delayed lipid clearance, the
use of lipids is contraindicated.
Infusion of Peripheral Nutrition
The catheter is inserted into the arm vein of the
patient.
Up to 1800-2500 kcal and 90g protein can be supplied
via PPN.
This relatively high kcalorie/protein amount can be
supported peripherally only for a short period of time.
11. Purposes
Used when individuals cannot or should not get
their nutrition through eating.
Used when the intestines are obstructed, when the
small intestine does not absorb nutrients properly,
or a GI fistula (abnormal connection) is present.
To ensure ‘Bowel rest’ (food does not pass through
the bowels).
[Bowel rest may be necessary in Crohn's disease,
pancreatitis, ulcerative colitis, and with prolonged
bouts of diarrhea in young children].
12. Purposes (contd’)
Used for individuals with severe burns, multiple
fractures, and in malnourished individuals to
prepare them for major surgery, chemotherapy, or
radiation therapy.
Individuals with AIDS or widespread infection
(sepsis) may also benefit from TPN.
To rehydrate a patient post-viral illness.
Patients with more serious and long term illnesses
and conditions may require months or even years
of intravenous therapy to meet their nutritional
needs. These patients may require a central
venous access port.
13. A specialized catheter (Silastic Broviac or Hickman)
is inserted beneath the skin and positioned below
the collarbone. Fluids can then be injected directly
into the bloodstream for long periods of time. X-
rays are taken to ensure that the permanent
catheter is properly positioned.
14.
15. Description
The hyperalimentation solution is infused through
conventional tubing with an IV filter attached to remove any
contaminates.
In adults, the catheter is placed directly into the subclavian
vein and threaded through the right innominate vein into the
superior vena cava.
In infants and small children the catheter is usually threaded
to the central venous location by way of the jugular vein
(which is entered through a subcutaneous tunnel beneath
the scalp). Sometimes, the umbilical vein is used.
Strict asepsis must be maintained because infection (sepsis
and septicaemia) is the primary risk.
Once the catheter is in place, a CXR is done to make sure
the placement is correct.
TPN solution is mixed daily under sterile conditions.
16. Description (contd’)
Maintaining sterility is essential for preventing infection.
- The outside tubing leading from the bag of solution to
the catheter must be changed daily.
- The special dressings covering the catheter must be
changed every other day.
17. Contents of the TPN solution
Are determined / individualized, based on the individual
variables (age, weight, height, and the medical
condition/s) .
All solutions contain
- sugar (dextrose) for energy
- proteins (AA)
- fats (lipids)
- electrolytes (K+
, Na+
, Ca+
, Mg+
, Cl-
and phosphate);
these are essential for normal body functioning.
- trace elements (Zn, Cu, Mn and Cr)
- vitamins
- insulin (helps the body use sugar), may need to be
added.
The TPN catheter is used only for nutrients;
medications are not added to the solution.
18. Contents of the TPN solution (contd.)
For Adults: approx. 2 lts of TPN solution daily (varies
with the individual’s age, size and health).
The solution should be allowed to be warmed to room
temperature before intravenous nutrition begins. The
solution is infused slowly at first to prevent fluid
imbalances, then the rate is gradually increased. The
infusion process takes several hours.
Successful TPN requires frequent, often daily
monitoring of the individual's parameters [weight,
glucose levels, FBC, blood gasses, fluid balance, urine
output, waste products in the blood (plasma urea);
electrolytes];
LFT & RFT may also be performed (special cases).
19. Conventional IV solutions are….
- sterile water with small amounts of sodium (salt) or
dextrose (sugar) supplied in bottles or thick plastic
bags that can hang on a stand mounted next to the
patient's bed.
- Additional minerals, vitamins, or drugs can be added
to the IV solution by injecting them into the bottle or
bag with a needle.
- These simple sugar and salt solutions can provide
fluids, calories, and electrolytes necessary for short
periods of time.
- If a patient requires IV feeding for more than a few
days, additional nutrients like proteins and fats will be
included. The amounts of each of the nutrients to be
added will depend on the patient's age, medical
condition, and particular nutritional requirements.
20. 3-in-1 solution : glucose, proteins and lipids
Infusion:
Medical Infusion pump:
- preferred method (sterile bag of nutrient solution + pump)
- pump infuses a small amount (0.1 to 10 mL/hr)
continuously in order to keep the vein open.
- feeding schedules vary, but normally the regimen ramps
up the nutrition over one hour, levels off the rate for a few
hours, and then ramps it down over a final hour (in order
to simulate a normal metabolic response resembling meal
time). This should be done over 12 to 24 hours rather than
intermittently during the day.
Chronic PN is performed through a central IV catheter,
usually through the subclavian or jugular vein with the tip of
the catheter at the superior vena cava without entering the
right atrium.
21. PICC line :
- Peripherally Inserted Central Catheter
- originates in the arm, and extends to one of the
central veins (such as the subclavian with the tip in
the superior vena cava).
22. Preparation
Preparation to insert the catheter involves creating a sterile
environment. Other special preparations are not normally
necessary.
Aftercare
During the time the catheter is in place, patients and caregivers
must be alert to any signs of infection (redness, swelling, fever,
drainage or pain).
Risks
TPN requires close monitoring.
Two types of complications can develop as a result of inserting
the catheter into a vein …
* Pneumothorax (infection, air in the lung cavities)
* Thrombosis (blood clot formation) subsequent to phlebitis.
Metabolic and fluid imbalances
* occur if the contents of the nutritional fluid are not properly
balanced and monitored.
* Hypoglycemia – most common metabolic imbalance;
caused by abruptly discontinuing a solution high in sugar.
23. Risks (contd.)
If the needle becomes dislodged, it is possible that the
solution may flow into tissues around the injection site
rather than into the vein.
24.
25. NUTRITIONAL COMPONENTS
Amino Acid (AA) Solutions
Protein is provided as a crystalline amino acid solution.
500 ml bottles are standard.
Solutions vary in amino acid concentration and
composition.
The patient's protein needs determine the protein
concentration to use.
The underlying disease state/s determines the
composition of amino acids to use.
26. Amino Acid Solutions/Concentrations
Amino acid (AA) solutions are generally available in the
following concentrations:
Percent Solution
(%)
AA Content
(g/100 mL)
3.0 3.0
3.5 3.5
5.0 5.0
7.0 7.0
8.5 8.5
10 10
27. Uses of Amino Acids
AAs do not normally contribute to the kcalorie
requirement of the patient (although they have 4 kcals
per gram).
Instead of being used for energy, amino acids should
be used for protein synthesis.
To determine protein needs, a nonprotein kcalorie to
nitrogen ratio of 80:1 to 150:1 is used.
Nonprotein kcal:N ratio
• 80:1 the most severely stressed patients
• 100:1 severely stressed patients
• 150:1 unstressed patient
28. Dextrose Solutions
Dextrose in solution has 3.4 kcals/gram (rather than 4
kcals/gram as in dietary carbohydrates), because a
noncaloric water molecule is attached to dextrose
molecules.
Dextrose solutions come in different concentrations,
and the solution is abbreviated D(%solution)W.
Eg.: D50W indicates a 50% dextrose in water solution.
29. Dextrose Solution Concentrations
Dextrose solutions are available in the following
concentrations:
Percent soln.
(%)
Dextrose
(g/100 ml)
Notation
5 5 D5W
10 10 D10W
20 20 D20W
30 30 D30W
40 40 D40W
50 50 D50W
60 60 D60W
70 70 D70W
30. Infusion Rate of Dextrose
Dextrose solutions should NOT be administered at a
rate higher than 0.36g per kg body weight/hour.
This is the maximum oxidation rate of glucose.
Excess glucose is converted to fat (which can result in
fatty liver).
The conversion of carbohydrate to fat can cause excess
CO2 production (which is undesirable for patients with
respiratory problems).
Calculation Example :
For 60 kgs patient,
0.36 x 60 kg x 24 hr = 518 grams per day
(Dextrose infusion should not be greater than 0.36g/kg/hr).
31. Calculate the maximum dextrose tolerance for the
following weights
Weight (kgs)
70
80
90
100
32. LIPID EMULSIONS
Lipids in PN are used as a source of essential fatty acids
(EFA) and energy.
Lipid emulsions are composed of soybean and/or
safflower oil, glycerol, and egg phospholipid.
Approx. 4% of total kcaloric intake should be EFAs to
prevent EFA deficiency.
IV lipids are a good source of kcalories for
hypermetabolic patients, or patients with volume or
carbohydrate restrictions (as they are isotonic and
calorically dense).
Lipids can provide upto 60% of non-protein calories.
Usually composed of long chain triglycerides (LCT).
In some cases, LCT + medium chain triglycerides
(MCT) may be beneficial.
33. F.Y.I.
Before lipids could be administered intravenously,
EFAs were provided by rubbing vegetable oil into the
patient's skin.
However, the efficacy of this procedure is
controversial, but it might be used in the case of patients
who cannot tolerate a lipid emulsion.
34. Lipid Emulsion Concentrations
IV lipids come in concentrations of 10% or 20%
emulsions.
The 10% emulsion contains 1.1 kcal/ml.
The 20% emulsion contains 2 kcal/ml.
Bottles come in 100 ml, 200 ml, 250 ml and 500 ml
volumes.
500 ml of 10% lipids given once or twice a week is
generally enough to prevent EFAs deficiency.
The lipid emulsion does not have to be mixed with the
AA and dextrose solutions in a single bag.
35. LIPID EMULSION ADMINISTRATION
Lipid emulsions are not provided continuously (to
prevent hyperlipidemia). This gives the body a chance
to clear lipids from the blood.
Usually, lipids are administered 1-2 times per week, but
can be provided daily, under stringent monitoring.
Recommended infusion times are 4-6 hours for 10%
lipids and 8-12 hours for 20% lipids.
12-24 hour infusions may be better tolerated by some
patients.
A total of 2.5g lipids /kg per day should not be
exceeded.
36. Calculation example of maximum daily lipids
For a 60 kg patient,
2.5g x 60 kg = 150g lipid per day maximum
Calculate maximum lipid tolerance for the following
weights:
Weight (kgs)
70
80
90
100
37. Evaluation of Lipid Tolerance
There are three methods that can be used for evaluation
of a patient's lipid tolerance:
Test Dose
Serum Triglycerides
Plasma Turbidity
38. Test Dose Method
10% lipid infused @ 1ml/min for 15-30 min; if no
adverse symptoms, the rate can be increased to
80 - 100 ml/h
OR
20% lipid emulsion infused @ 0.5 ml/min for 15 –
30 min; if no adverse symptoms, the rate can be
increased to 40 - 50 ml/h
39. Serum Triglyceride Method
Determine a baseline serum triglyceride level before
the emulsion is administered.
Determine the triglyceride level 8 hours after the
infusion has been terminated.
If serum triglycerides are normal or if they exceed
250 mg/day, lipids should be given at a reduced rate
or should be used only to prevent EFAs deficiency.
Plasma Turbidity Method
Plasma is observed for turbidity.
If turbidity is present, the lipid infusion must be
adjusted.
Not the best method for testing lipid tolerance,
because hyperlipidemia can occur without turbidity.
40. Contraindications for Lipid Emulsions
Abnormal lipid metabolism
Lipid nephrosis
Acute pancreatitis (if concomitant with or caused by
hyperlipidemia)
Severe egg allergies
Use lipid emulsions with caution if the patient has:
A blood coagulation disorder
Moderate to severe liver disease
Compromised pulmonary function
41. Administration of Lipids
Lipids are administered in a bottle that is ‘Y-connected’
(‘piggybacked’) to the IV line containing AA/dextrose
mixture.
Total nutrient admixtures (TNAs) also called ‘3-in-1
systems’, allow for lipids to be administered with AAs
and dextrose.
43. Mineral
State of Catabolism
Comments
Normal
(mEq)
Mild-Mod
(mEq)
Severe
(mEq)
Potassium 0.7 - 0.9 2.0 3.0 - 4.0 Give 5 - 6 mEq/g of N infused
Sodium 1.0 - 4.0 2.0 - 3.0 3.0 - 4.0
Calcium 0.22 0.3 0.4
0.25 m Eq/kg needed for calcium
equilibrium. Dependent on
simultaneous administration
of PO and Na, not N retention
Phosphorous 0.3 0.8 1.2 - 2.0
Needs related to nitrogen
retention which is related to
kcal intake. Give 15-25 mEq
PO per 1000 dex kcals.
Magnesium 0.3 0.3 - 0.4 0.6 - 0.8
Give 2 mEq per gram of N
infused.
Mineral needs (Amount per kg body weight)
45. Trace Elements
Requirements for standard trace element mixtures are
to be monitored and adjusted based on serum
concentrations.
Iron can be given intramuscularly as needed.
• When transferrin levels are low, free iron increases and
can increase susceptibility to infections.
• Critically ill or malnourished patients often have no
bone marrow response to iron.
Copper supplementation must be administered with
caution to avoid toxicity.
Extra zinc may be needed by some patients to promote
wound healing.
46. Element Dose
Zinc 2.5 - 4.0 mg
Copper 0.5 - 1.5 mg
Iron 1.0 mg
Chromium 10 - 15 mcg
Manganese 0.15 - 1.8 mg
Iodine 1 - 2 mcg
Selenium 20 - 40 mcg
47. Vitamins
The vitamin requirements for TPN patients are different
from non-TPN patients because absorption is not a
factor with TPN.
When needs are increased for certain disease states,
single vitamin supplements can be added to the
solution.
Serum vitamin levels can be monitored and dosage
adjusted accordingly.
Vitamin preparations should be added to the TPN
solution just prior to administration to avoid losses from
light exposure.